← Human Trials & Peer-Reviewed Studies
Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites.
Plain-language guide to PMID 2294131 (1990): randomized controlled trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
Key Facts
- PMID
- 2294131
- Journal
- The Journal of clinical endocrinology and metabolism
- Year
- 1990
- Study type
- Randomized Controlled Trial
- Authors
- Jørgensen JO et al. (6 authors)
- DOI
- 10.1210/jcem-70-1-207
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over), published as a randomized controlled trial.
Since serum GH in normal subjects displays a circadian variation with a major and consistent surge after the onset of sleep the researchers examined whether the time of GH administration in GH-deficient patients had any impact on its action.
Eight GH-deficient patients all underwent 3 4-week study schedules in random order: 1) evening (2000 h) sc GH injections, 2) morning (0800 h) sc GH injections, and 3) no GH administration.
Who Took Part
The age groups tagged for this paper are children and teenagers, both men and women.
How the Study Was Run
In design terms this was a randomized study.
Random assignment meant chance, not the researchers, decided who got Exogenous HGH, sermorelin & older GHRPs (why they're passed over) and who got the comparison, which limits bias.
What Was Measured
At the end of each period the patients were admitted to hospital for 24-h measurements of hormones and metabolites.
The subject headings attached to it are 3-Hydroxybutyric Acid, Alanine, Blood Glucose, Circadian Rhythm, Dwarfism, Pituitary, Glycerol and Growth Hormone.
What This Means in Plain Language
The paper is a randomized study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
The publication is from 1990 (The Journal of clinical endocrinology and metabolism), a journal based in United States.
More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.
Our Notes on the Compound
Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.